Australian Clinical Labs Ltd (ACL) — Cash Flow Quality Index
Australian Clinical Labs Ltd (ACL) has a Cash Flow Quality Index of 11.29x as of December 2025. Operating cash flow of AU$62.87 Million exceeds net income of AU$5.57 Million, indicating high earnings quality where cash backs reported profits. Explore ACL cash flow metrics to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Australian Clinical Labs Ltd Cash Flow Quality Index (2019–2025)
Historical Cash Flow Quality Index for Australian Clinical Labs Ltd across 12 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Australian Clinical Labs Ltd (ACL) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Australian Clinical Labs Ltd (2019–2025)
Year-by-year earnings quality comparison for Australian Clinical Labs Ltd. For live market cap and the full company financial profile, see how much is Australian Clinical Labs Ltd worth.
| Year | Quality Index | Operating CF (AUD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▲ +0.0% |
| 2024 | 5.64x | AU$182.80 Million | AU$32.43 Million | ▼ -15.5% |
| 2024 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +0.0% |
| 2023 | 6.67x | AU$159.59 Million | AU$23.93 Million | ▲ +66.6% |
| 2023 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +0.0% |
| 2022 | 4.00x | AU$143.68 Million | AU$35.90 Million | ▲ +151.1% |
| 2022 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▲ +0.0% |
| 2021 | 1.59x | AU$284.09 Million | AU$178.24 Million | ▼ -37.5% |
| 2021 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +0.0% |
| 2020 | 2.55x | AU$153.86 Million | AU$60.37 Million | ▲ +3.3% |
| 2020 | 2.47x | AU$101.74 Million | AU$41.26 Million | ▲ +0.0% |
| 2019 | 2.47x | AU$101.74 Million | AU$41.26 Million | — |